The role of anthrolysin O in gut epithelial barrier disruption during Bacillus anthracis infection
- PMID: 20188700
- PMCID: PMC4457453
- DOI: 10.1016/j.bbrc.2010.02.091
The role of anthrolysin O in gut epithelial barrier disruption during Bacillus anthracis infection
Abstract
Gastrointestinal (GI) anthrax, caused by the bacterial infection of Bacillus anthracis, posts a significant bioterrorism threat by its relatively high mortality rate in humans. Different from inhalational anthrax by the route of infection, accumulating evidence indicates the bypass of vegetative bacteria across GI epithelium is required to initiate GI anthrax. Previously, we reported that purified anthrolysin O (ALO), instead of tripartite anthrax edema and lethal toxins, is capable of disrupting gut epithelial tight junctions and barrier function in cultured cells. Here, we show that ALO can disrupt intestinal tissue barrier function in an ex vivo mouse model. To explore the effects of ALO in a cell culture model of B. anthracis infection, we showed that anthrax bacteria can effectively reduce the monolayer integrity of human Caco-2 brush-border expressor (C2BBE) cells based on the reduced transepithelial resistance and the increased leakage of fluorescent dye. This disruption is likely caused by tight junction dysfunction observed by the reorganization of the tight junction protein occludin. Consequently, we observe significant passage of vegetative anthrax bacteria across C2BBE cells. This barrier disruption and bacterial crossover requires ALO since ALO-deficient B. anthracis strains fail to induce monolayer dysfunction and allow the passage of anthrax bacteria. Together these findings point to a pivotal role for ALO within the establishment of GI anthrax infection and the initial bypass of the epithelial barrier.
2010. Published by Elsevier Inc.
Figures




Similar articles
-
Cellular functions and X-ray structure of anthrolysin O, a cholesterol-dependent cytolysin secreted by Bacillus anthracis.J Biol Chem. 2009 May 22;284(21):14645-56. doi: 10.1074/jbc.M807631200. Epub 2009 Mar 23. J Biol Chem. 2009. PMID: 19307185 Free PMC article.
-
The Bacillus anthracis cholesterol-dependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages.BMC Microbiol. 2006 Jun 21;6:56. doi: 10.1186/1471-2180-6-56. BMC Microbiol. 2006. PMID: 16790055 Free PMC article.
-
Bacillus anthracis anthrolysin O and three phospholipases C are functionally redundant in a murine model of inhalation anthrax.FEMS Microbiol Lett. 2007 Jun;271(1):98-105. doi: 10.1111/j.1574-6968.2007.00713.x. Epub 2007 Apr 10. FEMS Microbiol Lett. 2007. PMID: 17419764
-
Bacillus anthracis factors for phagosomal escape.Toxins (Basel). 2012 Jul;4(7):536-53. doi: 10.3390/toxins4070536. Epub 2012 Jul 10. Toxins (Basel). 2012. PMID: 22852067 Free PMC article. Review.
-
The effects of anthrax lethal toxin on host barrier function.Toxins (Basel). 2011 Jun;3(6):591-607. doi: 10.3390/toxins3060591. Epub 2011 Jun 14. Toxins (Basel). 2011. PMID: 22069727 Free PMC article. Review.
Cited by
-
Profiling lethal factor interacting proteins from human stomach using T7 phage display screening.Mol Med Rep. 2016 May;13(5):3797-804. doi: 10.3892/mmr.2016.5031. Epub 2016 Mar 21. Mol Med Rep. 2016. PMID: 27035230 Free PMC article.
-
Early Circulating Edema Factor in Inhalational Anthrax Infection: Does It Matter?Microorganisms. 2024 Jan 31;12(2):308. doi: 10.3390/microorganisms12020308. Microorganisms. 2024. PMID: 38399712 Free PMC article.
-
Listeriolysin O: A phagosome-specific cytolysin revisited.Cell Microbiol. 2019 Mar;21(3):e12988. doi: 10.1111/cmi.12988. Epub 2019 Jan 15. Cell Microbiol. 2019. PMID: 30511471 Free PMC article. Review.
-
Expressions of tight junction proteins Occludin and Claudin-1 are under the circadian control in the mouse large intestine: implications in intestinal permeability and susceptibility to colitis.PLoS One. 2014 May 20;9(5):e98016. doi: 10.1371/journal.pone.0098016. eCollection 2014. PLoS One. 2014. PMID: 24845399 Free PMC article.
-
Inflammatory mediators weaken the amniotic membrane barrier through disruption of tight junctions.J Physiol. 2010 Dec 15;588(Pt 24):4859-69. doi: 10.1113/jphysiol.2010.197764. Epub 2010 Nov 1. J Physiol. 2010. PMID: 21041526 Free PMC article.
References
-
- Beatty ME, Ashford DA, Griffin PM, Tauxe RV, Sobel J. Gastrointestinal anthrax: review of the literature. Arch Intern Med. 2003;163:2527–31. - PubMed
-
- Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med. 1999;341:815–26. - PubMed
-
- Inglesby TV, O’Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, Perl TM, Russell PK, Tonat K. Anthrax as a biological weapon, 2002: updated recommendations for management. Jama. 2002;287:2236–52. - PubMed
-
- Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799–809. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical